RxDoctor Payments Data

Shirley Goff, APRN

Nurse Practitioner · Pikeville, KYNPI 1386834273

Payments from drug & device makers

$2,118in general payments, 2019–2025

Across 128 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$206
  • Biohaven Pharmaceuticals, Inc.$126
  • Lilly USA, LLC$104
  • Daiichi Sankyo Inc.$75
  • Abbott$71
  • plus $496 from 15 others

What the payments were for

  • Food & beverage$2,118100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,118 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,252
Medicare patients
61
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl159$21,529
MounjaroTirzepatide12$12,041
FarxigaDapagliflozin Propanediol13$11,361
Methylprednisolone240$1,616
Sucralfate26$1,308
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort21$956
Albuterol Sulfate HfaAlbuterol Sulfate19$867
Ultra-Fine Short Pen NeedlePen Needle, Diabetic13$835
Doxepin Hcl14$618
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$594
Amoxicillin118$455
Ibuprofen28$368
Ranolazine ErRanolazine12$349
Azithromycin101$346
Cefdinir22$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$104$12,04112 claims
AstraZenecaFarxiga$30$11,36113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →